No items found.

Aegerion Pharmaceuticals is an indirect subsidiary of Novelion Therapeutics, a biopharmaceutical company dedicated to developing and commercialising therapies that deliver new standards of care for people living with rare diseases. With a global footprint and an established commercial portfolio, their business is supported by differentiated treatments for severe, rare diseases.